396 filings
Page 5 of 20
425
5do4fw32 ja2mjg
7 May 21
Business combination disclosure
7:08am
8-K
qem96iy5pjmwcii984
9 Mar 21
Acasti Pharma Provides Update on Recent Financing Activities
12:00am
8-K
hti1zos8h3k
9 Feb 21
Acasti Pharma Announces Results for Third Quarter of Fiscal 2021
4:35pm
8-K
uce0f
27 Jan 21
Acasti Pharma Provides Update on Recent Financing Activities
7:35am
8-K
awbhp9gr4x 4wp10b4g
4 Dec 20
Other Events
8:00am
8-K
djkeks4
16 Nov 20
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
7:05am
8-K
0yjbn08zlvartar6ewye
7 Oct 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:30am
8-K
itso7f
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
ioxur59 m5fi30
29 Sep 20
Acasti Announces Review Process of Strategic Alternatives
8:19am
8-K
jm2um9
17 Sep 20
Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer
9:54pm
8-K
28hx7
11 Sep 20
Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
7:00am
DEFA14A
oh5y8xyv d899k3pa858
11 Sep 20
Additional proxy soliciting materials
7:00am
DEF 14A
r9j pj321
9 Sep 20
Definitive proxy
4:00pm
8-K
1cwcf
31 Aug 20
Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia
4:05pm
10-Q
g3ppycdocx37turjs8
13 Aug 20
Quarterly report
8:30am
8-K
xslfcgfi9aspx3i2lh6
13 Aug 20
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
8:30am
PRE 14A
t0u7iobq6zh644h
10 Aug 20
Preliminary proxy
12:00am
8-K
k3a6txnn5j7om6d cc8
31 Jul 20
Regulation FD Disclosure
4:05pm